Neuralstem President And CEO To Present At The 2014 Rodman & Renshaw Annual Global Investment Conference Sep 5, 2014 09:15AM
Neuralstem Reports Second Quarter Financial Results And Provides Business And Clinical Update Aug 8, 2014 08:00AM
Final Patient Treated In Neuralstem Phase II ALS Stem Cell Trial Aug 4, 2014 09:15AM
Neuralstem Added To Russell 3000 Index Jun 30, 2014 09:15AM
Neuralstem's NSI-189 Novel Neurogenic Compound Shows Significant Effect In Major Depressive Disorder Jun 25, 2014 09:15AM